Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inv(12)(q15q24): a nonrandom change associated with myelodysplasia?

G Scantamburlo1, S Lampertz, C Croisiau

  • 1Department of Human Genetics, University of Liège, Center for Human Genetics, Sart Tilman, Belgium.

Cancer Genetics and Cytogenetics
|November 7, 2000
PubMed
Summary

This study describes a patient with refractory anemia and a rare chromosome 12 inversion. This finding suggests the inversion is a nonrandom change linked to myelodysplastic syndromes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of a highly-sensitive, quantitative LC-MS/MS assay to evaluate plasma oxytocin.

Journal of mass spectrometry and advances in the clinical lab·2025
Same author

[Environmental crisis and mental health].

Revue medicale de Liege·2022
Same author

[Deep brain stimulation as a treatment for severe multidrug-resistant obsessive compulsive disorder].

Revue medicale de Liege·2022
Same author

[Obesity and eating disorders].

Revue medicale de Liege·2021
Same author

[Catatonia, complicated withdrawal from benzodiazepines].

Revue medicale de Liege·2020
Same author

[Innovative therapeutic approaches in psychiatry : neuromodulation. For whom, why and how ?]

Revue medicale de Liege·2020

Area of Science:

  • Hematology
  • Cytogenetics
  • Oncology

Background:

  • Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
  • Refractory anemia is a common presentation of MDS, often associated with chromosomal abnormalities.
  • Understanding the genetic basis of MDS is crucial for diagnosis and treatment.

Observation:

  • A case of refractory anemia is presented with a specific paracentric inversion of chromosome 12, denoted as inv(12)(q15q24).
  • This represents the second documented instance of this particular chromosomal rearrangement.
  • The patient's clinical presentation and cytogenetic findings were meticulously analyzed.

Findings:

  • The paracentric inversion inv(12)(q15q24) is identified as a rare chromosomal anomaly.

Related Experiment Videos

  • This specific rearrangement appears to be nonrandomly associated with the development of myelodysplastic syndromes.
  • The recurrence of this anomaly suggests a potential role in MDS pathogenesis.

    • Implications:

    • The findings contribute to the understanding of the cytogenetic landscape of myelodysplastic syndromes.
    • This rare chromosomal abnormality may serve as a diagnostic or prognostic marker in select MDS cases.
    • Further research into the functional impact of inv(12)(q15q24) could elucidate MDS mechanisms.